Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
celgene
commissioner
2
×
detroit blog main
detroit top stories
fda
gene editing
indiana blog main
2
×
indiana top stories
ipo
2
×
life sciences
national
national blog main
national top stories
new york blog main
2
×
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
scott gottlieb
seattle blog main
seattle top stories
texas blog main
texas top stories
vc
venture capital
wisconsin blog main
wisconsin top stories
2025
abbvie
ac immune
acquisition
ad-comm
What
bio
roundup
allogene
biopharma
cancer
car
celgene
colleagues
crispr
diversity
exome
government
health
hot
hundreds
immunotherapy
industry
investors
ipo
juno
medicine
million
nearly
new
policy
published
ready
remains
sf
shares
snapped
stories
tales
therapeutics
ticket
utero
years
Language
Current search:
commissioner
×
ipo
×
" new york blog main "
×
" indiana blog main "
×
@xconomy.com
5 years ago
Bio Roundup: $74B for Celgene, Two CAR-T Tales, Ready for SF & More
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More